ROMILAC 0.5 Tablets – Cabergoline 0.5 mg
Description
Cabergoline Tablet IP 0.5 mg acts by selectively stimulating dopamine D2 receptors in the pituitary gland, effectively inhibiting excessive prolactin secretion and restoring hormonal balance. It provides a longer duration of action and superior tolerability compared to bromocriptine, allowing convenient once- or twice-weekly dosing. Cabergoline has demonstrated proven efficacy in managing hyperprolactinemia-related infertility and in the treatment of pituitary microadenomas and macroadenomas, offering reliable therapeutic outcomes with improved patient compliance.
Key Points
✅Powerful Dopamine Agonist: Efficiently suppresses prolactin secretion, supporting hormonal balance and reproductive health.
✅Prolonged Action & Ease of Use: Long-acting formulation allows once- or twice-weekly dosing for improved treatment adherence.
✅Excellent Tolerability: Demonstrates fewer gastrointestinal and neurological side effects than bromocriptine, ensuring better patient comfort.
Targeted specialties
✅Endocrinology
✅Gynecology
✅Infertility / Reproductive Medicine
✅Neurology (for pituitary disorders)
Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion.









